Showing results (631-640 of 802) with videos related to
Sort By:
Pageof 81
Journal of Molecular Biology|June 8, 2002
Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channelsMeng Cui, Jianhua Shen, James M Briggs, et al.The Patient|January 26, 2012
Stakeholder Satisfaction with the Australian Rheumatology Association Database (ARAD)Andrew M Briggs, Lyn March, Rosemarie van den Haak, et al.Plos One|November 9, 2018
Patients' perceived needs for medical services for non-specific low back pain: A systematic scoping reviewLouisa Chou, Tom A Ranger, Waruna Peiris, et al.International Journal of Rheumatology|February 5, 2010
Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association databaseAndrew M Briggs, Lyn March, Marissa Lassere, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous miceR M Ings, M Breen, K Devereux, et al.Osteoarthritis and Cartilage|February 25, 2017
Patients' perceived health service needs for osteoarthritis (OA) care: a scoping systematic reviewM C Papandony, L Chou, M Seneviwickrama, et al.Biophysical Journal|November 5, 2002
Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channelsWei Fu, Meng Cui, James M Briggs, et al.Circulation Research|September 9, 2008
Bestrophin-3 (vitelliform macular dystrophy 2-like 3 protein) is essential for the cGMP-dependent calcium-activated chloride conductance in vascular smooth muscle cellsVladimir V Matchkov, Per Larsen, Elena V Bouzinova, et al.Alternative Therapies in Health and Medicine|May 22, 2010
The effect of a contemplative self-healing program on quality of life in women with breast and gynecologic cancersJoseph J Loizzo, Janey C Peterson, Mary E Charlson, et al.Journal of Medicinal Chemistry|June 8, 2000
Developing a dynamic pharmacophore model for HIV-1 integraseH A Carlson, K M Masukawa, K Rubins, et al.Pageof 81